{"name":"Enzene Biosciences Ltd.","slug":"enzene-biosciences-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ENZ215","genericName":"ENZ215","slug":"enz215","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"ENZ215","genericName":"ENZ215","slug":"enz215","phase":"phase_3","mechanism":"ENZ215 is an investigational therapeutic targeting a specific molecular pathway in early-to-mid stage clinical development by Enzene Biosciences.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-02-17","type":"regulatory","source":"Indian Pharma Post","summary":"USFDA issues Form 483 with 6 observations to Enzene Biosciences’ Chakan plant following PAI - Indian Pharma Post","headline":"USFDA issues Form 483 with 6 observations to Enzene Biosciences’ Chakan plant following PAI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPcFdlTnk1WVRvV3htSlUxa0F0NnYzaExLdlVFUUlfTExiOE5ETGo0Ui03d01lMmFyZ2NRRnUwRU1QcXhzXzZwd0xac3BXZ0t1aEt4cEhjRkdvUHhtcUtjTmNuMWxrY1dfRXNhREpfajlpMVM1Zi0wRTNwNE1jTXYyeUctNVZNZVpXQ3c?oc=5","date":"2026-02-08","type":"pipeline","source":"lupin.com","summary":"Lupin Announces the Launch of Cetuximab - Lupin | Press Release - lupin.com","headline":"Lupin Announces the Launch of Cetuximab - Lupin | Press Release","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-12","type":"trial","source":"Medical Dialogues","summary":"SEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab Biosimilar - Medical Dialogues","headline":"SEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab Biosimilar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFBSdVNRSFkxWVl1UzdHd2JHeUFQRFZXMTdiSG1Db3FfZ0RWMzNIa3o4b2p5eGhMamUwOHZMT1VOQVJrNXpLWGN5a1c3bXZHUXU1NVI4OE91SFRIQ1lUY0EzREJR?oc=5","date":"2025-09-15","type":"pipeline","source":"NJBIZ","summary":"Enzene’s $50M biopharma plant expands NJ’s life sciences sector - NJBIZ","headline":"Enzene’s $50M biopharma plant expands NJ’s life sciences sector","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOVzEydkp2dEJVS2tSZ3A2N0pyQ1JIMUVXbWFNc2xzLUhaTDZIbjhYbm5KdllzVmtadnM4RGNqb3VJc3Y3WWpqOTR1R0RfUTVoZkpPemQ1LWdNQ0RsVGQtT3hQOHN4b0pYQWVPWktBeW5NNFZHMkFZNl9rX05tU0xPQy1pbFE1LVRHelIyMmhtcHNqVDctLWhvLQ?oc=5","date":"2025-09-04","type":"pipeline","source":"New Jersey Business Magazine","summary":"India’s Enzene Opens $50M Bio-Pharma Manufacturing Plant in Hopewell - New Jersey Business Magazine","headline":"India’s Enzene Opens $50M Bio-Pharma Manufacturing Plant in Hopewell","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOdHNVMTdhMEw5SzVwbHBWU3hWN1pPek1mcks4Nk1ZMHlMSnNmVllGeHNBWTZBT0lYQTBkaVVCNXZOcmRPQlM2Y2c4TXdaeEVnNFFmc0lCd3JNZzhnYm95Zy10Vnp1eFVtaGFueGNaeUFjZE82eDJNblBWTzQ4QXhMbHhOczJWcVU4Y09xTHQ5QUJFeXhETmtodTBVSGxlaEdf?oc=5","date":"2024-01-09","type":"pipeline","source":"Contract Pharma","summary":"Enzene Biosciences Opens First U.S. Manufacturing Plant - Contract Pharma","headline":"Enzene Biosciences Opens First U.S. Manufacturing Plant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPUmFQOXZ0ZnUxbHBqMW1QYkkyZlRtZkowMFU3MGtjNzd1OTIzWW1hU2RUQjhmRFdvWGVkN0NTdGZNVER5RmRHcndXV3llVGpFenY0OWpJY3pnNTdTVmIyZEg4SmNBOU92alVzVTRjTnpwNkV2TC1QN2p6OFlXeFJDNVRONU9lX2lFamFmMlRCRU5nemotZ0ptYXBxdXlFX1lvYnp4Q2ZacVpOVFE?oc=5","date":"2023-06-16","type":"pipeline","source":"RE-NJ","summary":"Indian biotech firm headed to Hopewell life sciences campus, eyes new manufacturing plant - RE-NJ","headline":"Indian biotech firm headed to Hopewell life sciences campus, eyes new manufacturing plant - RE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOaTF1bFplcFVjbk9meWpBVnpscURweWN5NmU1NW5aX0hlYVlhM0xMSlFjZV9SamtKTEJDUnEwMlo2ZkVPR2JvUUd3ZGhKb19CV19sX2tIUkRISF9GTWIyUFNOdTJyeTN1MUZmYzA5aDZYeTVVRmZVVzdkR1RJSml0bUlaUVJ4UlpvNUhOSmdibW9HSEc3TUxvYndOVHpsVU11X1kyZkExM0hTY3NRZ0NsUHAzOA?oc=5","date":"2023-06-15","type":"pipeline","source":"New Jersey Business Magazine","summary":"India’s Enzene Biosciences to Open a $50M Bio-Manufacturing Plant in Hopewell - New Jersey Business Magazine","headline":"India’s Enzene Biosciences to Open a $50M Bio-Manufacturing Plant in Hopewell","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPdUE2QjhNNFVRWjVOUUE5NGE3ZjJmQjh4aFJGZzV2RVNlN1pnYmJMVjZYbEQzY0tmSTREdXhXUldkeEFxanhiV0RTa09FSkhoaHFvREVQS1V2YUx1T1N0ajZuckdCU0lFSGFpZnZXRndGbThUdjZFanFOdEtPUVJlY003Y082T1k5WnBHcFc5YTNBN2plbE9YdGlOSWFkYTd0UndTYlR6Ykk4d1QxSE5xTVJn?oc=5","date":"2023-06-15","type":"pipeline","source":"Contract Pharma","summary":"Enzene Biosciences Expanding to New Jersey Bio Manufacturing Plant - Contract Pharma","headline":"Enzene Biosciences Expanding to New Jersey Bio Manufacturing Plant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOSjZDM3dKWFA4UlVDZkNtc1RBZEdGOXRCMVlhTVVNbHdPcWdBc25rcUVtZV9pajZFc0R0Vy1WcWh3bDh1emJlcm52czdlR25pQzJYR3Y3b3cxeWZkRXh6R0JVbFh6ZmNnenZZeUVPTnh3aFdCWk95eDczc0g3UHhxMjZXOWhMbS1rRW8yMjhWaWd6WmV6MUFJZUFtQkRMTVE4c1lad05BejJ4MDg5T3dIZXlqMHVUMDJOdVhxM3pn?oc=5","date":"2023-03-01","type":"patent","source":"Healthcare Radius","summary":"Enzene Biosciences launches biosimilar as rheumatoid arthritis medication - Healthcare Radius","headline":"Enzene Biosciences launches biosimilar as rheumatoid arthritis medication","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQQVpRdFlBUF8xZnFQTUwzX0ZfWTFwWW10ZDBGaWl0T0NyTm5jRThqMEstVTQzcERaTmRwUTNuVUhNczhVUjFtSXV4UTBHblBCdmxEZkRUeHl4a3U5aENLeHI1WURyVGtvMjRjci1ZdzFITlNmakRkcmcxcGliTGlDZ2xaOF8yN2NkTVpETm5IdEF4b3BacUZGb1dLWXF6cmhyVTJ6cWJiRnNrUWtPSVRKZjlRaEZBdGNuTmJsOWVIYTRZRzhlMnk0WjZ2QXNKQnNuVTRvdGZ1Vjc4QQ?oc=5","date":"2021-08-29","type":"patent","source":"BioPharma APAC","summary":"Enzene Biosciences Ltd. obtains a Marketing Authorization for its Denosumab Biosimilar drug in India - BioPharma APAC","headline":"Enzene Biosciences Ltd. obtains a Marketing Authorization for its Denosumab Biosimilar drug in India","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNd01hMHFWV2g3UGRmZGtIbmN6X3g1Zi1RRmZnSFRrNXdaTThwUFJ0ZVFwcUVrV3RBYmIwdzBVUXNPMW03WHB1YWNLMUdMRnlkeExXdW1rUVRHSXllWS02eUV6d1ZKVFBtWXo5Y1duV2trc3MzbFlvMHZyRHRMQllJNmt1QlloUW5aNktaazE5SHJkT1RPZ3JvazIxQUh1ZmpI?oc=5","date":"2021-06-25","type":"patent","source":"Generics and Biosimilars Initiative","summary":"Theramex to market Prolia biosimilar in Europe and Australia - Generics and Biosimilars Initiative","headline":"Theramex to market Prolia biosimilar in Europe and Australia","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}